Cite
Cholesterol and neurodegeneration: longitudinal changes in serum cholesterol biomarkers are associated with new lesions and gray matter atrophy in multiple sclerosis over 5 years of follow‐up.
MLA
Murali, N., et al. “Cholesterol and Neurodegeneration: Longitudinal Changes in Serum Cholesterol Biomarkers Are Associated with New Lesions and Gray Matter Atrophy in Multiple Sclerosis over 5 Years of Follow‐up.” European Journal of Neurology, vol. 27, no. 1, Jan. 2020, p. 188. EBSCOhost, https://doi.org/10.1111/ene.14055.
APA
Murali, N., Browne, R. W., Fellows Maxwell, K., Bodziak, M. L., Jakimovski, D., Hagemeier, J., Bergsland, N., Weinstock, G. B., Zivadinov, R., & Ramanathan, M. (2020). Cholesterol and neurodegeneration: longitudinal changes in serum cholesterol biomarkers are associated with new lesions and gray matter atrophy in multiple sclerosis over 5 years of follow‐up. European Journal of Neurology, 27(1), 188. https://doi.org/10.1111/ene.14055
Chicago
Murali, N., R. W. Browne, K. Fellows Maxwell, M. L. Bodziak, D. Jakimovski, J. Hagemeier, N. Bergsland, Guttman, B. Weinstock, R. Zivadinov, and M. Ramanathan. 2020. “Cholesterol and Neurodegeneration: Longitudinal Changes in Serum Cholesterol Biomarkers Are Associated with New Lesions and Gray Matter Atrophy in Multiple Sclerosis over 5 Years of Follow‐up.” European Journal of Neurology 27 (1): 188. doi:10.1111/ene.14055.